Diethylstilbestrol (DES) is a synthetic estrogen that has been used in the treatment of advanced human prostate cancer (/) . Diethylstilbestrol diphosphate (DESdP) has been shown to be a nontoxic pro-drug form of DES (2, 5) . The palliative effects of DESdP administered to advanced, hormone-insensitive prostate cancer patients have been known for some time (3) (4) (5) (6) . DESdP has been shown to relieve bone pain in the majority of patients with metastatic prostate cancer who are receiving therapy (7). Schulz et al. (8) have reported that DESdP is directly cytotoxic only after dephosphorylation to DES. DESdP may offer a selective therapeutic advantage in prostate cancer patients because of the conversion of DESdP to DES in the acid phosphatase-rich environment of the prostate (5) .
Theoretically, administration of estrogenic analogues such as DES and DESdP causes suppression of luteinizing hormonereleasing-factor stimulation of the pituitary gland (9) . Subsequent reduction of testosterone synthesis produces anorchid levels of circulating serum testosterone (9) . Daily doses of 3 mg DES have been demonstrated to reproducibly lower levels of serum testosterone to the concentration range observed in castrated patients (9) . The beneficial effect of DES therapy in previously orchiectomized patients, however, indicates that DES may not operate solely through the pituitary-gonadal axis. Several studies have sought to define the mode of DES action on a cellular level. Estrone and DES treatments inhibit growth of primary cultures derived from benign hyperplasia and prostate carcinoma samples (JO) and in prostate cancer cell lines (8) . Intracellular localization studies of DES inhibition have targeted mitochondrial adenosine triphosphate synthase (//), respiratory chain enzymes (8) , and microtubules (J2J3) as sites of action. Hartley-Asp et al. (13) reported that DES induced metaphase arrest in DU145 prostate cancer cells. Other investigators (14, 15) have found that DES increased aneuploidy in mammalian cells. It was reported that DES inhibited in vitro polymerization of tubulin into microtubules, although the exact location of DES binding to tubulins or microtubule-associated proteins was not determined (76). Studies with estramustine, a structural analogue of 17p-estradiol, have shown that the 17P-estradiol carbamate linkage to nitrogen mustard may be important for binding to microtubule-associated proteins. Clinical trials of estramustine and vinblastine, both microtubule inhibitors, in the treatment of hormone-refractory prostate cancer patients have indicated that these drugs show promise for inducing antitumor responses (17) . Similar antimitotic effects have been ascribed to tamoxifen (18), a compound structurally similar to DES. Estrogen receptors are present in some prostate cancer cells (19) . It is unclear whether their presence is an important factor in prostate cancer response to either estrogens or antiestrogens.
This study was designed to investigate the inhibitory action of DES and DESdP on cultured prostate cancer cells and to examine estrogen receptor modulation of such effects.
Materials and Methods

Cell Lines and Culture Media
The androgen-insensitive prostate cancer cell lines 1-LN, DU145, and PC-3 (20) (21) (22) were maintained in RPMI-1640 medium (Sigma Chemical Co., St. Louis, MO) supplemented with 5% fetal bovine serum (FBS) (Life Technologies, Inc. [GIBCO BRL], Gaithersburg, MD) and were replated at lower cell density with 0.25% trypsin-EDTA (Life Technologies, Inc.) twice weekly. LNCaP, an androgen-sensitive prostate cancer cell line (23) , was maintained in the same growth medium enriched with 10% FBS and 5 mL of ITS+ (i.e., insulin, transferrin, and selenium; Collaborative Research, Inc., Bedford, MA). LNCaP cells were passaged by gentle agitation with phosphate-buffered saline (PBS) (Life Technologies, Inc.).
Preparation of Compounds
DES was obtained from Sigma Chemical Co. DESdP was donated as a liquid preparation (Stilphostrol; Miles Pharmaceuticals, West Haven, CT). DESdP was diluted to appropriate concentrations with either culture medium containing heat-inactivated serum or culture medium containing non-heat-inactivated serum. 17(i-Estradiol was acquired from Upjohn Co. (Kalamazoo, MI). DES and 17fi-estradiol were solubilized in dimethyl sulfoxide (DMSO) (Fisher Scientific Co., Raleigh, NC) and were subsequently diluted in culture media to a final DMSO concentration of less than 0.1 % (vol/vol). DMSO alone was not toxic to these cells at concentrations of less than 0.1 % (vol/vol). Colchicine was obtained from Sigma Chemical Co. and solubilized in growth media.
MTT Assay
Cell viability was determined by use of the microculture tetrazolium technique (MTT) (24) . The MTT assay provides a quantitative measure of the number of viable cells by determining the amount of formazan crystals produced by metabolic activity in treated versus control (i.e., untreated) cells. Cultures were initiated in 96-well plates (Corning Costar Corp., Cambridge, MA) at 5 x 10 3 cells per well. Cells were allowed to reattach overnight and were then exposed to DES, DESdP, or I7fi-estradiol for 72 hours. Compounds were added to final concentrations within the range of 0-50 \lM. In the l7p-estradiol-DES-reversibilily experiments, cells were first exposed to various concentrations of DES (0-50 \iM) for 24 hours followed by the addition of 50 juW nfi-estradiol for 48 hours. At the end of the treatment period. 50 uX of 12 UJW MTT reagent |3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyl-tetrazolium bromide in PBS] was added to each well. The plates were reirtcubated at 37 'C for 4 hours in the dark. Supernatant was aspirated, and formazan crystals were solubilized in 150 uL DMSO at 37 "C for 10 minutes with gentle agitation. The absorbance per well was measured at 540 nm by use of an EL311 Microplate Reader (Biotek Instruments Inc.. Winoski. VT) linked to a computer (Macintosh LC 475). Each assay was performed at least three times with a matrix of three to six replicate wells per drug concentration.
Statistics and LD50 Calculations
Statistical analyses were performed using the Statview II program (Abacus Concepts, Inc.. Berkeley, CA). Cell viability curves were plotted from absorbance readings as a function of drug concentration by use of CA-CncketGraph III (vl.5) software (Computer Associates International. Islandia. NY). LD,,, values (the dose at which 50% of cells are no longer viable) were derived from best fit curves. Statistical analyses of the differences between mean LD,,, values were determined by use of Student's / test (two-tailed) to obtain P values.
Analysis of Estrogen Receptor Levels
Semiquantitative analyses of estrogen receptor levels were performed by the Cell Imaging Laboratory at Duke University Medical Center by the method of Layfield et al. (Layfield LJ, Sana E, Conlon D, Kerns BJ: manuscript submitted for publication). Briefly, cells were grown to confluence in 75-cm 2 flasks and washed with PBS before fixation in 10% neutral buffered formalin (Baxter, Deerfield, IL) for 30 minutes with gentle rocking. Cells were scraped off the flasks in 10% neutral buffered formalin, pelleted at 600^ for 4 minutes at 25 'C, and washed three times with cold PBS. Cell pellets were embedded in paraffin, and sections of 5 ^m in thickness were cut on a microtome and mounted on clean glass slides. The slides were baked overnight at 65 'C. The following morning, they were cooled for 30 minutes at room temperature. They were then deparaffinized in xylene and rehydrated in decreasing concentrations of ethanol. The slides were heated in a pressure cooker with 1500 mL of 10 mM citrate buffer (pH 6.0) (Ventana Medical Systems Inc., Tucson, AZ) for 30 minutes in a 700-W microwave and then cooled for 30 minutes. The slides were washed in Ventana Buffer Solution and loaded into the Ventana 320 Automated Immunostainer. The estrogen receptor primary antibody was supplied in a prediluted form by Ventana Medical Systems Inc. The detection system was a universal anti-rabbit secondary immunoglobulin G (IgG)-biotinylated antibody cocktail followed by an avidin-biotin conjugate (Ventana Medical Systems Inc.). Staining was visualized by diaminobenzidine chromogen with a copper sulfate enhancement. The slides were counterstained with 1% methyl green (Sigma Chemical Co.) in sodium acetate buffer (pH 5.2). Quantitative analyses were performed on a CAS200 Image Analyzer by use of the quantitative ER/PgR Software Package Version 2.51 (Becton Dickinson/Cell Analysis Systems, Chicago, IL). The CAS200 Image Analyzer was calibrated with an estrogen receptor-positive breast tissue sample with a predetermined quantity of estrogen receptors.
Immunofluorescence and UV Microscopy
PC-3 cells were plated on sterile coverslips in six-well tissue culture dishes at 1 x 10 3 cells per well. Cells were allowed to reattach overnight: the next day, they were exposed to DES (0-50 \iM) or to colchicine (0.01-1.0 \lM) for 24. 48, and 72 hours. They were then rinsed with PEM buffer (50 mM PIPES [pH 6.9], 10 mM EGTA, and 6 mM MgSO 4 ) (Sigma Chemical Co.) and made permeable for 1 minute at 37 'C with 0.5% Triton X-100 in PEM. Following a 10-minute fixation with 4% paraformaldehyde, cells were rinsed three times with PEM and incubated for I hour at room temperature with 0.5% preimmune goat serum in Hanks' balanced salt solution (Life Technologies, Inc.). Cells were then incubated for I hour with monoclonal anti-^-tubulin antibody (clone TUB 2.1, diluted 1:1000 in PBS) (Sigma Chemical Co.). After incubation, cells were rinsed three times with PEM and incubated with either (a) fluorescein isothiocyanate-labeled goal anti-mouse IgG (TAGO Inc., Burlingame, CA), (b) tetramethylrhodamine-isothiocyanate-labeled phalloidin (Sigma Chemical Co.) to stain filamentous actin, or (c) 4\6-diamidino-2-phenylindole (Sigma Chemical Co.) to stain DNA. Cytospin slides were prepared for comparison. Briefly, PC-3 cells were plated in 100-mm dishes at 5 x 10 5 cells per dish and allowed to recover overnight. Cells were then exposed to either DES (0-30 \lM) or DESdP (0-30 \iM) for 72 hours. Adherent and nonadherent cells were collected and centnfuged at 400g for 10 minutes at 25 'C (i.e., cytospun) on glass slides. Slides were air-dried overnight and frozen at -20 'C. 
DNA Gel Electrophoresis
PC-3 cells were harvested while in log-phase growth by trypsin treatment. They were then plated at a density of 5 x 10 s cells per 100-mm dish. Cells were allowed to recover for 24 hours, and DES was added at a concentration of 15 or 30 UJW. Dishes with or without drug were incubated for 24, 48, or 72 hours. Adherent and nonadherent cells were harvested in PBS, centrifuged at 600g for 10 minutes at 25 "C, and frozen at -20 "C until time of assay. DNA was then extracted and electrophoresed by the method of Borner et al. (25) . Cells were centrifuged at 600g for 5 minutes at 25 'C, and the resultant pellets were lysed in 10 mM Tris-HCl (pH 7.4), 25 mM EDTA, and 0.1% Nonidet P^O. The samples were exposed to 500 Hg/mL proteinase K for 2 hours at 55 'C. The lysate was centrifuged at 30 OOOg for 2 hours at 4 "C in an Optima TLX Ultracentrifuge (Beckman Instruments, Palo Alto, CA). The supernatant was treated with 100 |ig/mL nbonuclease (RNase) (Sigma Chemical Co.) and incubated for 18 hours at 37 'C. DNA was precipitated in 2 volumes of 100% ethanol for 20 minutes at 4 'C and harvested at maximal speed in a microfuge. DNA pellets were resuspended in distilled water and loaded in a 1.0% agarose gel. DNA was electrophoresed for 1.5 hours at 10 V/cm. Gels were shaken in 100 mL distilled water containing 30-40 (jL ethidium bromide (10 mg/mL) (Sigma Chemical Co.) and photographed under UV light.
Fluorescence Flow Cytometry
Cells were harvested at log phase by trypsin treatment and plated at a density of 5 x 10 3 cells per 100-mm tissue culture dish. Cells were allowed to replate and grow for 24 hours before DES or DESdP was added at various concentrations bracketing the LDj,, values (15-30 \lM) . Cells with and without drug were incubated for 72 hours, and then adherent and nonadherent cells were harvested. Approximately 1 x 10 6 cells were centrifuged at 600g for 5 minutes at 25 'C, and the supernatant was removed. The pelleted cells were resuspended in 1 mL of nuclear isolation medium (i.e., 9 mM CaCl 2 , 3 mM KCI, 1 mM KH 2 PO 4 , 5 mM MgCI 2 , 137 mM NaCl, 8 mM Na 2 HPO 4 , 0.5% bovine serum albumin [Sigma Chemical Co.], 0.2% nonionic detergent, and Nonidet P-40 [Sigma Chemical Co.]). RNA was digested by the addition of 10 |iL (10 mg/mL) deoxyribonuclease-free RNase (Sigma Chemical Co.) to the nuclear preparation. The isolated nuclei were stained by the addition of 10 nL propidium iodide (5 mg/mL) (Sigma Chemical Co.). The stained nuclei were kept in the dark at 4 "C for 24 hours before analysis on a FACScan II flow cytometer (Becton Dickinson, Franklin Lakes, NJ). Fluorescence DNA histograms were generated from DNA signal width versus DNA signal area to identify the Go/G,, S, and Gj/M populations on the basis of the relative propidium iodide (DNA) fluorescence. The G, peak was placed at about one third the propidium iodide-fluorescence scale, and the lower discriminator was set at about channel 10 to capture the hypodiploid region of fluorescence (just below the G, peak) but to exclude the signals present in the lowest channels. The lower cutoff was set and kept exactly at the same position for the analysis of the DES-or DESdP-treated cells. The upper discriminator was sel to exclude cell doublets or clumps but to include nuclei with aneuploid or polyploid DNA content.
Results
Heat Inactivation of FBS
DESdP inhibited the growth of PC-3 cells grown in medium supplemented with non-heat-inactivated FBS. There was an (Fig. 1) . All subsequent assays for DESdP were therefore carried out with nonheat-inactivated serum-supplemented media.
Comparison of DESdP-Induced and DES-Induced Cytotoxicity
As summarized in Table 1 , the LD50 values (means ± standard error) for DESdP were in the range of 20.6 (iAf ± 1.9 \iM to 25.0 \iM ± 3.4 \iM, with a group LD50 mean of 23.0 |iM ± 1.0 \iM. DESdP reduced the viability of each of the cell lines by 50% at concentrations of approximately 20 \iM. The LD 50 values (means ± standard error) for DES were within a range of 19.6 \xM ± 0.6 \iM to 21.7 \iM ± 4.0 \iM, with a group LDm ean of 20.9 \xM ± 0.5 \xM DES. The differences between group LD50 means for DES and DESdP were not statistically significant (Table 1) . Representative trypan blue dye exclusion hemocytometer counts verified observed cell number reductions measured by the MTT assays.
17(3-Estradiol Receptor Analysis
To test the responsiveness of these cell lines to a natural estrogen, we added 17p-estradiol to growth media at concentrations ranging from 0 to 50 \iM. 17|}-Estradiol stimulated growth of LNCaP cells but did not affect the growth of 1 -LN, PC-3, and DU145 cells at the concentrations tested. The presence of estrogen receptors was also analyzed in these cell lines. 1-LN, DU145, and PC-3 cells were negative for estrogen receptor (i.e., <5 fmol/pg DNA), whereas LNCaP cells were positive for estrogen receptor (>10 fmol/pg DNA). Table 1 summarizes these results and gives previously reported results relating to the androgen sensitivity of these cell lines (82326). There was no apparent association between estrogen receptor positivity or androgen sensitivity and the cyotoxic effects of either DES or DESdP in these prostate cancer cell lines (Table 1) . However, the growth of LNCaP cells, positive for estrogen receptors, was stimulated by the addition of exogenous 17fJ-estradiol, as shown by the increase in MTT optical density or control cells in Fig. 2 .
Failure of 17(i-Estradiol to Reverse DES-Induced Cytotoxicity
17p-Estradiol rescue of DES-treated cells was not observed in triplicate assays combining both agents in four separate cell lines. Cells were pretreated with DES (0-50 (lAf) for 24 hours, and 17P-estradiol was added at a concentration of 50 \iM for an additional 48 hours, after which cell viability was measured by the MTT assay. There was no apparent difference in loss of viability for prostate cancer cells exposed to DES in the absence or presence of 50 \iM 17p-estradiol. Fig. 2 shows the results of such an experiment with LNCaP cells.
Immunofluorescence and UV Microscopy
It had been previously suggested that DES inhibits microtubule formation (13) . To examine this issue, we studied changes in microtubule architecture in control versus DEStreated PC-3 cells. Colchicine, a known microtubule inhibitor, was used as the positive control (2728). Compared with control (untreated) cells (Fig. 3, A) , microtubules in PC-3 cells treated for 72 hours with 0.1 \xM colchicine were completely disrupted (Fig. 3, B) . However, microtubules were not altered by a 72-hour exposure to 15 |iM DES (Fig. 3, C) or 30 \LM DES (Fig. 3,  D) . Actin filaments in these cells were also unaffected by DES at the same concentrations (data not shown).
UV light fluorescence microscopy of cells grown on coverslips or of cytospin preparations stained with the DNA fluorochrome 4',6-diamidino-2-phenylindole revealed the presence of apoptotic nuclei in PC-3 cells treated with DES or DESdP (Fig.  4) . Cells treated with DES for 72 hours had smaller nuclei often associated with a scalloped outline (Fig. 4, B; arrows) . A small number of apoptotic nuclei were also observed in control cells at the 72-hour time point (arrows in Fig. 4, C and E) . Cytospin preparations were also analyzed by staining with 4',6-diamidino-2-phenylindole to determine whether DES or DESdP increased the proportion of "mitotic" nuclei within the G2/M population. Nuclei with condensed chromatin or "chromosomes," as in metaphase, anaphase, and telophase, were infrequently seen in cytospin or coverslip preparations of control or DES-or DESdP-treated cells (arrowheads in Fig. 4 , A, B, C, E). In agreement with the flow cytometry data, this observation suggests that a small number of mitotic cells are represented in the G2/M subpopulation. 
Observation of Apoptosis by Electrophoresis
PC-3 cells treated with DES were examined by DNA extraction and electrophoresis on a 1.0% agarose gel (Fig. 5) . A DNA pattern suggestive but not diagnostic of apoptosis was noted at the 48-and 72-hour time points for 15 and 30 \iM DES exposures. There was no low-molecular-weight DNA in the control lanes, and there was a clear dose-and time-dependent response to DNA fragmentation with DES (Fig. 5) . A small amount of DNA fragmentation was observed within the 24-hour time limit with 30 \xM DES. The induction of apoptosis was dependent on time and concentration.
Flow Cytometric Analysis
DES and DESdP have been shown to induce metaphase arrest and to inhibit growth of a variety of mammalian cells (13) . It was therefore of interest to determine whether DES and DESdP could also disrupt cell cycle progression in cultured prostate cancer cells. A disruption or blockage of the cell cycle is expressed in the DNA profile of cells in the various stages of the cell cycle. Such a profile is readily obtained by means of propidium iodide-fluorescence flow cytometry. Fluorescence discriminators were lowered to detect the incidence of hypodiploid bodies at propidium iodide-fluorescence levels below the 2N DNA level. The appearance of propidium iodidestained nuclei with aneuploid chromosome complement (i.e., DNA content <2N) was therefore detectable. Propidium iodidefluorescence (DNA) profiles were obtained for the four cell lines exposed to DES and DESdP at concentrations bracketing the LD 50 
values (15 and 30 \xM)-
A flow cytometric analysis for PC-3 nuclei is shown in Fig. 6 . The cell cycle phases are defined in terms of propidium iodidefluorescence units on the abscissa: Hypodiploid bodies (nuclei) -10-50, G, phase = 50-75, S phase = 75-125, and G2/M phase = 125-150. The frequency of hypodiploid nuclei and the distribution (%) of cells within each cycle phase were calculated from histograms for each cell line ( Table 2 ). All androgen-insensitive cells had an increase in apoptotic percent, whereas androgensensitive LNCaP cells had an increase in apoptotic percent to a lesser degree. A pronounced decrease in the proportion of G| cells in each of the androgen-insensitive prostate cancer cell lines (1-LN, DU145, and PC-3) was observed in cell lines exposed to either DES or DESdP. For DES-treated cells, a decrease in S-phase cell number was noted; a similar but less pronounced decrease occurred in DESdP-treated cells. An increase in the proportion of nuclei in G2/M phase was noted in all DES-treated, androgen-insensitive prostate cancer cell lines, but only PC-3 cells responded to DESdP with an increase in G2/M. In contrast, androgen-sensitive LNCaP cells showed no change in the proportion of cells in G) or S phase and a decrease in the proportion of cells in G2/M phase after treatment with DES or DESdP.
Discussion
In this study, DES and DESdP were equally cytotoxic to prostate adenocarcinoma cells, regardless of androgen sensitivity (Table 1) or estrogen receptor status (Fig. 2) . Our experiments implicate the presence of heat-labile phosphatases in serum and support the previously published work of Schulz et al. (8) . DES is a synthetic estrogen and should exhibit similar effects as those exhibited by other estrogenic compounds, i.e., 17p-estradiol. Estrogen receptor analysis did reveal that LNCaP cells were estrogen receptor positive and that androgen-insensitive cell lines were estrogen receptor negative. Even though the growth of LNCaP cells was stimulated by 17P-estradiol (Fig. 2) , a similar effect with DES was not seen (Table 1) . On the contrary, we found that DES abrogated 17p-estradiol stimulation of LNCaP cells, yielding LD^ values that were essentially equal to those seen with no 17p-estradiol stimulation. Our findings agree with previous results (29) that revealed a similar effect of estramustine on prostate cancer cells independent of the presence of estrogen receptors. These observations have led us to conclude that DES-induced growth inhibition is not mediated via the estrogen receptor but may involve alternate cellular mechanisms.
In previous studies, investigators (13, 15) have observed DESinduced mitotic spindle disruptions in vitro. Hartley-Asp et al. (13) noted that DES-induced mitotic arrest in DU145 prostate cancer cells was accompanied by inhibition of microtubule assembly. This inhibition was reversible and required high concentrations of DES (up to 100 |iAf). On the basis of UV fluorescence microscopic analysis of 4',6-diamidino-2-phenylindole-stained nuclei of DES-and DESdP-treated PC-3 cells (Fig.  4) , there is little evidence in our study to indicate that these cells were arrested at mitosis. The preponderance of apoptotic nuclei was most likely blocked at the G2/M interface, which is in agreement with the DNA fluorescence flow cytometry profiles shown in Fig. 6 . DES-induced microtubule inhibition has also been shown in breast cancer cell lines. Aizu-Yokota et al. (12) reported the occurrence of microtubule inhibition in breast cancer cell lines, regardless of the presence of estrogen receptor. However, microtubular inhibition was induced at DES concentrations more than twofold higher (80 \iM) than those used in this study (15-30 \iM) . Immunofluorescence microscopy failed to demonstrate DES inhibition of microtubule formation in PC-3 prostate cancer cells (15-30 fiM) . Our results agree more with the work of Sharp and Parry (30) , who showed enhanced microtubular assembly at low concentrations (10 \iM DES). Of interest were the apoptotic nuclei observed by UV fluorescence microscopy of DES-or DESdP-treated PC-3 cells (Fig.  4) . We have also used a variety of techniques to detect DNA fragment ladder formation, a characteristic gel electrophoretic band pattern associated with apoptosis (25JI-37). However, absence of ladder formation in DNA gels does not rule out apoptosis. Three methodologies for the isolation and electrophoresis of DNA were employed in our laboratory (25J8J9). Although we were able to obtain agarose gels with DNA fragmentation by using all three methods, we found that the method described by Borner et al. (25) produced the best results for DES-treated cells. Low-molecular-weight DNA fragmentation was noted at 24-, 48-, and 72-hour time points when cells were exposed to DES. Increasingly smaller fragments of DNA were noted at the 48-and 72-hour time points (Fig. 5) , indicating a time-and dose-dependent induction of apoptosis by DES. In agreement with the flow cytometric data, a more extensive DNA degradation pattern was seen on agarose gels. Control cells with no DES exposure had no DNA degradation, which suggests that DES induced DNA fragmentation. Considered together with the microscopic evidence for condensed nuclei and the flow cytometric evidence for an apoptotic sub-G! peak, these data strongly suggest that DES induced apoptosis. Barry et al. (40) suggested that nucleosomal fragments may be transiently present during apoptosis, most likely as a result of the dynamic nature of the time course of DNA digestion. They also proposed that the nucleosome-length DNA may represent only the end product of excessive digestion and that nucleosomal fragments may be lost or digested further. Thus, while the presence of DNA ladders is consistent with apoptosis, the absence of DNA ladders does not rule out apoptosis either. Sawada and Ishidate (14) noted in DES-treated Chinese hamster fibroblasts histologic features consistent with the apoptotic changes described for the DES-and DESdP-treated PC-3 cells examined in this article. Expression of testosteronerepresssed prostatic message 2 (TRPM-2) messenger RNA (mRNA) has been associated with the induction of apoptosis in cells of the rat ventral prostate following castration (i.e., androgen ablation) (41) . Similarly, higher levels of TRPM-2 mRNA have been observed in human prostate xenograft tumor cells following castration of the host animals (42) . In a study of normal rat ventral prostate (43) , DES increased TRPM-2 expression for a longer time than did castration. DES-induced chromatin condensation has also been observed (44) . Evaluating 25 prostate cancer patients treated with DES, Szende et al. (45) noted the occurrence of apoptosis in biopsy specimens of tumor tissue from 20 (80%) of 25 patients, along with clinical tumor regression. Histologic evidence of apoptosis included foci of pyknosis and nuclear fragmentation. Such morphologic changes are consistent with the nuclear disruption (Figs. 3 and 4) and DNA fragmentation (Fig. 5 ) observed in our in vitro study.
Following previously described methodology (46) (47) (48) , fluorescence flow cytometry was used in this study to detect apoptotic cells. Wei et al. (47) noted that apoptosis was accompanied by a decrease in G| and S phases of the cell cycle upon tumor exposure to quercetin, a growth-inhibiting bioflavinoid. In our study, androgen-insensitive prostate cancer cells (1-LN, DU145, and PC-3) responded in a similar manner when treated with DES or DESdP: The percentage of cells in G] and S phases decreased as the percentage of G2/M and hypodiploid nuclei increased (Table 2 ). G2/M arrest is commonly caused by DNAdamaging agents (49^0). We found normal arrays of microtubules in DES-treated PC-3 prostate cancer cells, suggesting that disruption of microtubules was not the cause of the G2/M block. Sorenson et al. (49) described such events associated with G2-phase arrest and subsequent apoptosis in LI210 murine leukemia cells treated with cisplatin. Cells were shown to progress to G 2 phase and to remain arrested for several days, followed by a slow death at the G2/M transition (49). Barry et al. (40) proposed the following: "There are two forms of apoptosis, a rapid, and presumably more direct, activation of the endonuclease, and a delayed activation that requires passage to a specific cell cycle phase, the G-JM phase, and the activation of events normally associated with the G2/M phase transition."
Events that occur in this phase of the cell cycle may therefore be involved in the onset of apoptosis. One of the essential proteins for passage through G2/M is cyclin B (57) . Cyclin B complexes with p34/cdc2 and phosphorylates structural proteins such as the spindle apparatus (52) . Histone HI, which is involved in chromatin condensation, is also phosphorylated by the cyclin B-p34/cdc2 complex (52) . Preliminary immunohistochemical analyses in our laboratory revealed that cyclin B expression is decreased in DES-treated, androgen-insensitive prostate cancer cells. A link may exist between apoptosis, cyclin B-p34/cdc2 complex, and Gj arrest (50^3,54) . The androgen- sensitive prostate cancer cell line LNCaP did not show a decrease in the proportion of cells in G| phase after treatment with DES and DESdP but did show a decrease in the proportion of cells in the G2/M phase, which was concurrent with a slight increase in hypodiploid nuclei ( Table 2) . Details of the mechanism of DES-induced apoptosis and its relationship to cyclin B expression, however, are currently unknown.
Our results highlight the induction of apoptosis and cell cycle arrest upon prolonged exposure to DES or DESdP. The intensity of this phenomenon appears to depend on the androgen sensitivity of prostate cancer cells under study. Androgen-insensitive prostate cancer cells were more susceptible to DES-induced apoptosis than were androgen-sensitive prostate cancer cells. Whether high-dose DES treatment represents a window of opportunity for hormone-insensitive prostate cancers will require carefully conducted clinical studies tailored by pharmacokinetic monitoring. Further laboratory and clinical studies are warranted.
